QA: Ocera Therapeutics Inc in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001274644_2016_Ocera_Therapeutics_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001274644, Ocera Therapeutics Inc

  xvar xval
0 AssetsCurrent 44,022,000
1 IntangibleAssetsNetIncludingGoodwill 595,000
2 PropertyPlantAndEquipmentNet 94,000
3 remainder_Assets 26,000
4 LiabilitiesCurrent 3,834,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 9,509,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,410,249
9 ResearchAndDevelopmentExpense 15,803,372
10 remainder_Expenses 170,479
11 remainder_Revenues 139,067
12 remainder_NetIncome 272,925
13 remainder_ComprehensiveNetIncome -18,262
  yvar yval
0 Assets 44,737,000
1 Liabilities 13,343,000
2 Expenses 26,384,100
3 Revenues 139,067
4 StockholdersEquity 31,394,000
5 NetIncome -25,972,108
6 ComprehensiveNetIncome -25,981,239
7 BaseVar 42,447,177
8 EconomicCapitalRatiobeforeLimitedLiability 1.46
9 EconomicCapitalRatio 2.65

Edgar->Model Mapping

Feature Distribution

Change over Time